Advertisement

Topics

Latest Antibodies NewsRSS

22:38 EDT 21st October 2017 | BioPortfolio

Mononucleosis Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Mononucleosis diagnostics market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Mononucleosis definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Comme...

Coxsackievirus Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Coxsackievirus definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Co...

Report of Successful OMS721 Treatment of Patient with Both Stem Cell Transplant-Associated Thrombotic Microangiopathy and Graft-versus-Host Disease Presented at EBMT Annual Meeting

-- Results May Expand Target for Omeros’ Planned Phase 3 Program in HCT-TMA -- Omeros Corporation (NASDAQ: OMER) today announced the presentation of a case report of a patient having co-existing hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA) and graft-versus-host disease (GvHD), which both resolved following OMS72...

Ajinomoto Althea Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryAjinomoto Althea Inc Ajinomoto Althea offers contract manufacturing and contract development services to pharmaceutical and biotechnology industries. The service portfolio of the company includes process development, drug substance manufacturing platforms, microbial cell banking, phaseappropriate analytical development and validation, and drug product manufacturing. Its services also includ...

Bevacizumab improves survival in NSCLC patients

In what could be good news for recently approved bevacizumab biosimilar Mvasi, a study has shown that bevacizumab-containing regimens improve survival in advanced non-squamous non–small cell lung cancer (NSCLC) patients.

Legionella Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Legionella diagnostics market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Legionella definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Commercial/...

Campylobacter Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Comme...

Innova Biosciences Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryInnova Biosciences Ltd Innova, a subsidiary of Sygnis AG is a provider of bioconjugation technologies and services. The company products include antibody labeling kits, antibody purification kits, affinity resins, gold nanoparticle kits, immunogen kits, rapid Ab labeling kits and others. It provides maleimide activated labels, substrates and stabilizers, phosphate detection, and oligonucleo...

Enterovirus Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Enterovirus definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Commercia...

Aeromonads Diagnostic Testing Market 2021: Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Commercial/Pr...

Proteintech Europe Ltd Awarded new SUPC Antibodies and Sera Framework Agreement

Proteintech Europe Ltd, a direct manufacturer of antibodies, has been selected as a trusted supplier of research-grade antibodies as part of the new SUPC (Southern Universities Purchasing Consortium) Antibodies and Sera Inter Regional Laboratories Agreement. The UK-wide framework agreement supplies 6 higher education consortia, members of which in...

Juno taps Trianni for mAb discovery platform

Juno Therapeutics has signed a licensing agreement with Trianni for use of its monoclonal antibody (mAb) discovery platform.

Italy Hepatitis Diagnostic Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $3900

Complete report $3,900.nbsp; DataPack test volumes, sales forecasts, supplier shares $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides fiveyear test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, AntiHBc, AntiHBs, AntiHAV, Hepat...

Global MABS Market Analysis 20112017 and Forecast 20182023 [Report Updated: 18012017] Prices from USD $2980

SnapshotMABS is a copolymer of methyl methacrylate, acrylonitrile, butadiene, styrene, and it has ordinary ABS resin's mechanical properties, but higher impact toughness and transparency than ABS.The global MABS market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size ...

BioPorto Diagnostics AS Medical Equipment Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryBioPorto Diagnostics AS BioPorto Diagnostics, formerly AntibodyShop AS is an invitro diagnostics company that manufactures and markets antibodies and antibody based products. The company provides product such as matched reagent set, immunoassays, antigens, antibodies, controls calibrators and matched antibody pairs among others. It also offers cell biology products, NGAL rapid ELISA Kit and...

Rubella Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities [Report Updated: 13092017] Prices from USD $4350

The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Commercial/Priva...

Vanderbilt Researchers Find Novel Mechanism Of Resistance To Anti-Cancer Drugs

NewsSome targeted anti-cancer therapies are mainstays of treatment for advanced colorectal cancer. However, many patients have tumors with genetic mutations that make them resistant to these antibodies, or the cancers develop resistance during treatment.

Abzena and UGA Biopharma partner to develop a cell line expressing a biosimilar therapeutic for Multiple Sclerosis.

Cambridge, UK, and Hennigsdorf, Germany 19 September 2017 – Abzena plc (AIM: ABZA, 'Abzena' or the 'Group'), the life sciences group providing integrated solutions and technologies enabling the development and manufacture of biopharmaceutical products, and UGA Biopharma GmbH, a cell line development specialist, announce the completion of the development of a biosimilar cell...

Why did one-quarter of patients in one study stop taking their biosimilar? Subjective health complaints say experts

One-quarter (24%) of people who were switched from infliximab to a biosimilar version stopped taking the biosimilar due to health complaints during a six-month follow-up period, highlights research in Arthritis & Rheumatology. A biosimilar is a biological medicine that shows no clinically meaningful differences with an approved biological medicine. Healthcare systems around the world are [R...

Abzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for Multiple Sclerosis

Abzena plc (AIM: ABZA, 'Abzena' or the 'Group'), the life sciences group providing integrated solutions and technologies enabling the development and manufacture of biopharmaceutical products, and UGA Biopharma GmbH, a cell line development specialist, announce the completion of the development of a biosimilar cell line to treat Multiple Sclerosis (MS). ...

Three-in-One Antibody Prevents Acquisition by Monkeys of an SHIV Virus

One hundred percent of monkeys that received a trispecific antibody were protected from SHIV infection.

The Re-emergence of Gemtuzumab Ozogamicin for AML

Today we are speaking with Jorge Cortes, MD, who specializes in the treatment and clinical research of leukemia at M.D. Anderson Cancer Center in Houston, Texas, about treatment of patients with acute myeloid leukemia (AML) in the context of a new drug approval for the disease. Gemtuzumab ozogamicin (Mylotarg) an antibody drug conjugate, consisting of a recombinant, humanized anti-CD33 monoclonal ...

Global Bovine Colostrum Market Analysis 20112017 and Forecast 20182023 [Report Updated: 01092017] Prices from USD $2980

SnapshotBovine Colostrum is a milky fluid that comes from the breasts of cows the first few days after giving birth, before true milk appears. It contains proteins, carbohydrates, fats, vitamins, minerals, and proteins antibodies that fight diseasecausing agents such as bacteria and viruses. Antibody levels in colostrums can be 100 times higher than levels in regular cow's milk.The global Bovine C...

XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has...

Global Intravenous Immunoglobulin IVIg Market Analysis 20112017 and Forecast 20182023 [Report Updated: 22092017] Prices from USD $2980

SnapshotIntravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or lot of Intravenous Immunoglobulin.The global Intravenous Immunoglobulin IVIg market will reach Volume Million USD in 2017 and CAGR xx% 20112017. Th...

Quick Search
Advertisement
 

review and buy Antibodies market research data and corporate reports here